These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11475676)

  • 1. [Neuroleptic malignant syndrome with rhabdomyolysis and muscle rupture].
    Nikić S; Jović-Stosić J; Vucinić S; Todorović V; Babić G; Srnić D; Djordjević D; Stojanović V; Spasić V
    Vojnosanit Pregl; 2001; 58(2):199-203. PubMed ID: 11475676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)].
    Lazzarin M; Benati F; Cesario V
    Recenti Prog Med; 1996 Sep; 87(9):422-4. PubMed ID: 9053957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
    Marsh SJ; Dolson GM
    Ren Fail; 1995 Jul; 17(4):475-8. PubMed ID: 7569118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol-induced rhabdomyolysis without neuroleptic malignant syndrome in a handicapped child.
    Yoshikawa H; Watanabe T; Abe T; Oda Y; Ozawa K
    Brain Dev; 2000 Jun; 22(4):256-8. PubMed ID: 10838114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome and dopaminergic blockade.
    Hashimoto F; Sherman CB; Jeffery WH
    Arch Intern Med; 1984 Mar; 144(3):629-30. PubMed ID: 6703834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome and myopathy: a case report of lithium and haloperidol intoxication].
    Chen CC; Chen SS; Wen JK
    Taiwan Yi Xue Hui Za Zhi; 1985 Dec; 84(12):1371-9. PubMed ID: 3869643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of malignant neuroleptic syndrome with rhabdomyolysis and a therapeutic trial using physostigmine].
    Krull F; Risse A
    Fortschr Neurol Psychiatr; 1986 Dec; 54(12):398-401. PubMed ID: 2880787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome.
    Atbasoglu EC; Ozguven HD; Can Saka M; Goker C
    J Clin Psychiatry; 2004 Dec; 65(12):1724-5. PubMed ID: 15641884
    [No Abstract]   [Full Text] [Related]  

  • 19. Amisulpride and neuroleptic malignant syndrome.
    Tu MC; Hsiao CC
    Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report.
    Tanaka K; Akechi T; Yamazaki M; Hayashi R; Nishiwaki Y; Uchitomi Y
    Support Care Cancer; 1998 Nov; 6(6):536-8. PubMed ID: 9833304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.